Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?

Purpose: The pO2 threshold of an ideal PET hypoxia tracer for radiotherapy planning in cancer would match those observed in clinically and biologically relevant processes such as radioresistance and HIF1α expression. To identify such tracers, we directly compared uptake in vitro of hypoxia PET trace...

Full description

Bibliographic Details
Main Authors: Blower, P.J (Author), Chia, K. (Author), Landau, D. (Author), Mullen, G.E.D (Author), Naeem, M. (Author), Paul, R.L (Author), Weeks, A.J (Author)
Format: Article
Language:English
Published: Elsevier Inc. 2022
Subjects:
PET
Online Access:View Fulltext in Publisher
LEADER 03091nam a2200277Ia 4500
001 10.1016-j.nucmedbio.2022.04.004
008 220706s2022 CNT 000 0 und d
020 |a 09698051 (ISSN) 
245 1 0 |a Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy? 
260 0 |b Elsevier Inc.  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1016/j.nucmedbio.2022.04.004 
520 3 |a Purpose: The pO2 threshold of an ideal PET hypoxia tracer for radiotherapy planning in cancer would match those observed in clinically and biologically relevant processes such as radioresistance and HIF1α expression. To identify such tracers, we directly compared uptake in vitro of hypoxia PET tracers ([18F]FMISO, [64Cu]CuATSM, and analogues [64Cu]CuATS, [64Cu]CuATSE, [64Cu]CuCTS, [64Cu]CuDTS, [64Cu]CuDTSE, [64Cu]CuDTSM) with levels of radioresistance and HIF1α expression in cultured cancer cells under identical hypoxic conditions ranging from extreme hypoxia to normoxia. Pimonidazole uptake was also compared as a marker of hypoxia. Methods: A custom-built hypoxia apparatus enabled all experiments to be performed under identical hypoxic conditions with constant measurement of pO2 in media using an OxyLab pO2™ probe. HCT116 human colonic carcinoma and MCF-7 human Caucasian breast adenocarcinoma cells were irradiated using a cobalt teletherapy unit. Clonogenic assays were used to assess survival. HIF1α expression was determined by western blotting, tracer uptake by gamma counting and pimonidazole binding by flow cytometry. Results: Radioresistance, pimonidazole binding and HIF1α expression increased gradually as pO2 decreased between 25 mmHg and 0 mmHg. In contrast, all the PET hypoxia tracers showed a sharp increase in uptake only when pO2 levels fell below 1 mmHg. Above this threshold, tracer uptake was not elevated above that in normoxic cells. Conclusion: This study highlights an important mismatch in pO2 thresholds between these PET tracers and other markers of hypoxia: tracer uptake only occurred at oxygen levels that were well below levels that induced radioresistance, pimonidazole uptake and HIF1α expression. Although their pO2 thresholds do not match the threshold for resistance to conventionally fractionated radiotherapy (pO2 2.5–10 mmHg), their specificity for extreme hypoxia (pO2 ≪ 1 mmHg) suggests these PET tracers may be of particular use to predict outcomes in stereotactic radiation therapy where these maximally resistant cells play a key role in determining the biological effect. © 2022 The Authors 
650 0 4 |a HIF1α 
650 0 4 |a Hypoxia 
650 0 4 |a PET 
650 0 4 |a Radioresistance 
650 0 4 |a Stereotactic radiation therapy 
650 0 4 |a Tracer 
700 1 0 |a Blower, P.J.  |e author 
700 1 0 |a Chia, K.  |e author 
700 1 0 |a Landau, D.  |e author 
700 1 0 |a Mullen, G.E.D.  |e author 
700 1 0 |a Naeem, M.  |e author 
700 1 0 |a Paul, R.L.  |e author 
700 1 0 |a Weeks, A.J.  |e author 
773 |t Nuclear Medicine and Biology